Recurrent event analysis for time to dropout of newly-enrolled MMT participants in Guangdong, China: a retrospective study using the Prentice-Williams-Peterson model

References

• Amorim LD, Cai J. 2015. Modelling recurrent events: a tutorial for analysis in epidemiology. Int J Epidemiol. 44(1):324–333.
   PubMed Web of Science ®Google Scholar
• ASAM. 2020. The ASAM National Practice Guideline for the treatment of opioid use disorder: 2020 focused update. J Addict Med. 14:1–91.
   Web of Science ®Google Scholar
• Bagheri A, Saadati M. 2021. Determinants of birth intervals using Prentice-Williams-Peterson-Gap Time Model: Tehran case study. Int J Fertil Steril. 15(3):234–240.
   PubMed Web of Science ®Google Scholar
• Bell J, Burrell T, Indig D, Gilmour S. 2006. Cycling in and out of treatment; participation in methadone treatment in NSW, 1990–2002. Drug Alcohol Depend. 81(1):55–61.
   PubMed Web of Science ®Google Scholar
• Braga JR, Tu JV, Austin PC, Sutradhar R, Ross HJ, Lee DS. 2018. Recurrent events analysis for examination of hospitalizations in heart failure: insights from the Enhanced Feedback for Effective Cardiac Treatment (EFFECT) trial. Eur Heart J Qual Care Clin Outcomes. 4(1):18–26.
   PubMed Web of Science ®Google Scholar
• Deng SK, Weng SQ. 2017. Investigation report about the trend change of drug addicts in Guangdong province. Justice of China, 3:85–91.
   Google Scholar
• Dennis BB, Sanger N, Bawor M, Naji L, Plater C, Worster A, Woo J, Bhalerao A, Baptist-Mohseni N, Hillmer A, et al. 2020. A call for consensus in defining efficacy in clinical trials for opioid addiction: combined results from a systematic review and qualitative study in patients receiving pharmacological assisted therapy for opioid use disorder. Trials. 21(1):30.
   Web of Science ®Google Scholar
• Donny EC, Walsh SL, Bigelow GE, Eissenberg T, Stitzer ML. 2002. High-dose methadone produces superior opioid blockade and comparable withdrawal suppression to lower doses in opioid-dependent humans. Psychopharmacology. 161(2):202–212.
   PubMed Web of Science ®Google Scholar
• Durand L, O'Driscoll D, Boland F, Keenan E, Ryan BK, Barry J, Bennett K, Fahey T, Cousins G. 2020. Do interruptions to the continuity of methadone maintenance treatment in specialist addiction settings increase the risk of drug-related poisoning deaths? A retrospective cohort study. Addiction. 115(10):1867–1877.
   PubMed Web of Science ®Google Scholar
• Harvey LM, Fan WH, Cano MA, Vaughan EL, Arbona C, Essa S, Sanchez H, de Dios MA. 2020. Psychosocial intervention utilization and substance abuse treatment outcomes in a multisite sample of individuals who use opioids. J Subst Abuse Treat. 112:68–75.
   PubMed Web of Science ®Google Scholar
• Hser YI, Evans E, Grella C, Ling W, Anglin D. 2015. Long-term course of opioid addiction. Harv Rev Psychiatry. 23(2):76–89.
   PubMed Web of Science ®Google Scholar
• Hser YI, Longshore D, Anglin MD. 2007. The life course perspective on drug use: a conceptual framework for understanding drug use trajectories. Eval Rev. 31(6):515–547.
   PubMed Web of Science ®Google Scholar
• Jia CF, Bin H, Qing M, Hong, B, S. 2015. Analysis of factors associated with dropout of methadone maintenance treatment in Guiyang. Chinese J Dis Contr Prevent. 19(12):1215–1219.
   Google Scholar
• Kermode M, Choudhurimayum RS, Rajkumar LS, Haregu T, Armstrong G. 2020. Retention and outcomes for clients attending a methadone clinic in a resource-constrained setting: a mixed methods prospective cohort study in Imphal, Northeast India. Harm Reduct J. 17(1):68.
   PubMed Web of Science ®Google Scholar
• Khue PM, Tham NT, Mai DTT, Van Thuc P, Thuc VM, Van Han P, Lindan C. 2017. A longitudinal and case-control study of dropout among drug users in methadone maintenance treatment in Haiphong, Vietnam. Harm Reduct J. 14(1):59.
   PubMedGoogle Scholar
• Lambdin BH, Masao F, Chang O, Kaduri P, Mbwambo J, Magimba A, Sabuni N, Bruce RD. 2014. Methadone treatment for HIV prevention-feasibility, retention, and predictors of attrition in Dar es Salaam, Tanzania: a retrospective cohort study. Clin Infect Dis. 59(5):735–742.
   PubMed Web of Science ®Google Scholar
• Lin CK, Hung CC, Peng CY, Chao E, Lee TS. 2015. Factors associated with methadone treatment duration: a Cox regression analysis. PLOS One. 10(4):e0123687.
   PubMed Web of Science ®Google Scholar
• Lin HC, Chen KY, Wang PW, Yen CF, Wu HC, Yen CN, Yeh YC, Chung KS, Chang HC. 2013. Predictors for dropping-out from methadone maintenance therapy programs among heroin users in southern Taiwan. Subst Use Misuse. 48(1–2):181–191.
   PubMed Web of Science ®Google Scholar
• Mattick RP, Ali R, Lintzeris N. 2009. Pharmacotherapies for the treatment of opioid dependence: efficacy, cost-effectiveness and implementation guidelines. Boca Raton (FL): CRC Press.
   Google Scholar
• McLellan AT, Lewis DC, O'Brien CP, Kleber HD. 2000. Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA. 284(13):1689–1695.
   PubMed Web of Science ®Google Scholar
• Mitsuhashi T. 2020. Effects of indium exposure on respiratory symptoms: a retrospective cohort study in Japanese workers using health checkup data. PeerJ. 8:e8413.
   PubMed Web of Science ®Google Scholar
• Moyer RA, Ridgeway G. 2020. The effect of outpatient methadone maintenance treatment facilities on place-based crime. J Exp Criminol. 16(2):227–245.
   Web of Science ®Google Scholar
• National Institute on Drug Abuse. 2018. Principles of drug addiction treatment: a research-based guide (Third Edition). U.S. Department of Health and Human Services, National Institutes of Health.
   Google Scholar
• Nolan S, Lima VD, Fairbairn N, Kerr T, Montaner J, Grebely J, Wood E. 2014. The impact of methadone maintenance therapy on hepatitis C incidence among illicit drug users. Addiction. 109(12):2053–2059.
   PubMed Web of Science ®Google Scholar
• Nosyk B, MacNab YC, Sun HY, Fischer B, Marsh DC, Schechter MT, Anis AH. 2009. Proportional hazards frailty models for recurrent methadone maintenance treatment [Article; Proceedings Paper]. Am J Epidemiol. 170(6):783–792.
   PubMed Web of Science ®Google Scholar
• O'Connor AM, Cousins G, Durand L, Barry J, Boland F. 2020. Retention of patients in opioid substitution treatment: a systematic review. PLOS One. 15(5):e0232086.
   PubMed Web of Science ®Google Scholar
• Palepu A, Tyndall MW, Joy R, Kerr T, Wood E, Press N, Hogg RS, Montaner JSG. 2006. Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy. Drug Alcohol Depend. 84(2):188–194.
   PubMed Web of Science ®Google Scholar
• Prentice RL, Williams BJ, Peterson AV. 1981. On the regression analysis of multivariate failure time data. Biometrika. 68(2):373–379.
   Web of Science ®Google Scholar
• Rosen D, Hunsaker A, Albert SM, Cornelius JR, Reynolds CF. 2011. Characteristics and consequences of heroin use among older adults in the United States: a review of the literature, treatment implications, and recommendations for further research. Addict Behav. 36(4):279–285.
   PubMed Web of Science ®Google Scholar
• Rui Z, Rui Z, Min Z, Tie Q, L, Xin Z, D, Jing L. 2017. Guidelines for the diagnosis and treatment of opioid use related disorders. Chinese J Drug Abuse Prevent Treat. 23(1):1–3.
   Google Scholar
• Sagara I, Giorgi R, Doumbo OK, Piarroux R, Gaudart J. 2014. Modelling recurrent events: comparison of statistical models with continuous and discontinuous risk intervals on recurrent malaria episodes data. Malar J. 13(1):293.
   PubMedGoogle Scholar
• Scheibe A, Shelly S, Gerardy T, von Homeyer Z, Schneider A, Padayachee K, Naidoo SB, Mtshweni K, Matau A, Hausler H, et al. 2020. Six-month retention and changes in quality of life and substance use from a low-threshold methadone maintenance therapy programme in Durban, South Africa. Addict Sci Clin Pract. 15(1):13.
   PubMed Web of Science ®Google Scholar
• Sees KL, Delucchi KL, Masson C, Rosen A, Clark HW, Robillard H, Banys P, Hall SM. 2000. Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial. JAMA. 283(10):1303–1310.
   PubMed Web of Science ®Google Scholar
• Shakira R. H W, Sarimah A, Norsa’adah B. 2017. Factor predictive of 1-year retention on methadone maintenance therapy program: a survival analysis study Addict Disord Their Treat. 16(2):64–69.
   Google Scholar
• Shen J, Wang M, Wang X, Zhang G, Guo J, Li X, Li J. 2016. Predictors of poor adherence to methadone maintenance treatment in Yunnan Province, China. J Addict Med. 10(1):40–45.
   PubMed Web of Science ®Google Scholar
• Sordo L, Barrio G, Bravo MJ, Indave BI, Degenhardt L, Wiessing L, Ferri M, Pastor-Barriuso R. 2017. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies. BMJ. 357:1550.
   PubMed Web of Science ®Google Scholar
• Soyka M, Trader A, Klotsche J, Haberthur A, Buhringer G, Rehm J, Wittchen HU. 2012. Criminal behavior in opioid-dependent patients before and during maintenance therapy: 6-year follow-up of a nationally representative cohort sample. J Forensic Sci. 57(6):1524–1530.
   PubMed Web of Science ®Google Scholar
• Sullivan SG, Wu Z, Detels R, National Methadone Maintenance Treatment Working Group. 2013. Time to first treatment interruption in the Chinese methadone maintenance treatment programme. Drug Alcohol Depend. 133(2):427–432.
   PubMed Web of Science ®Google Scholar
• Teesson M, Mills K, Ross J, Darke S, Williamson A, Havard A. 2008. The impact of treatment on 3 years’ outcome for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS). Addiction. 103(1):80–88.
   PubMed Web of Science ®Google Scholar
• Thiede H, Hagan H, Murrill CS. 2000. Methadone treatment and HIV and hepatitis B and C risk reduction among injectors in the Seattle area. J Urban Health. 77(3):331–345.
   PubMed Web of Science ®Google Scholar
• Tran BX, Ohinmaa A, Mills S, Duong AT, Nguyen LT, Jacobs P, Houston S. 2012. Multilevel predictors of concurrent opioid use during methadone maintenance treatment among drug users with HIV/AIDS. PLOS One. 7(12):e51569.
   PubMed Web of Science ®Google Scholar
• Tsui JI, Evans JL, Lum PJ, Hahn JA, Page K. 2014. Association of opioid agonist therapy with lower incidence of hepatitis C virus infection in young adult injection drug users. JAMA Intern Med. 174(12):1974–1981.
   PubMed Web of Science ®Google Scholar
• Wei L. 2021, October 13-15. National methadone maintenance therapy and HIV prevention [Conference presentation]. The seventh national academic conference on HIV/AIDS, Beijing, China.
   Google Scholar
• Wei XL, Wang LR, Wang XL, Li JS, Li HX, Jia W. 2013. A study of 6-year retention in methadone maintenance treatment among opioid-dependent patients in Xi’an. J Addict Med. 7(5):342–348.
   PubMed Web of Science ®Google Scholar
• WHO. 2009. Clinical guidelines for withdrawal management and treatment of drug dependence in closed settings. https://www.ncbi.nlm.nih.gov/books/NBK310658/.
   Google Scholar
• Wong KH, Lee SS, Lim WL, Low HK. 2003. Adherence to methadone is associated with a lower level of HIV-related risk behaviors in drug users. J Subst Abuse Treat. 24(3):233–239.
   PubMed Web of Science ®Google Scholar
• Yang F, Lin P, Li Y, He Q, Long Q, Fu X, Luo Y. 2013. Predictors of retention in community-based methadone maintenance treatment program in Pearl River Delta, China. Harm Reduct J. 10(1):3.
   PubMedGoogle Scholar
• Zaller ND, Bazazi AR, Velazquez L, Rich JD. 2009. Attitudes toward methadone among out-of-treatment minority injection drug users: implications for health disparities. Int J Environ Res Public Health. 6(2):787–797.
   PubMed Web of Science ®Google Scholar
• Zhang L, Zou X, Zhang D, Li X, Zhao P, Ling L. 2015. Investigation of repeat client drop-out and re-enrolment cycles in fourteen methadone maintenance treatment clinics in Guangdong, China. PLOS One. 10(10):e0139942.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Shi CX, McGoogan JM, Rou K, Zhang F, Wu Z. 2013. Methadone maintenance treatment and mortality in HIV-positive people who inject opioids in China. Bull World Health Organ. 91(2):93–101.
   PubMed Web of Science ®Google Scholar
• Zhou K, Li H, Wei X, Li X, Zhuang G. 2017. Medication adherence in patients undergoing methadone maintenance treatment in Xi’an, China. J Addict Med. 11(1):28–33.
   PubMed Web of Science ®Google Scholar
• Zhou K, Zhuang G. 2014. Retention in methadone maintenance treatment in mainland China, 2004–2012: a literature review. Addict Behav. 39(1):22–29.
   PubMed Web of Science ®Google Scholar